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putorized database and defined criteria Cases with potential PA rupture were 
reviewed In detail Patients with only pulmonary edema or psoudoaneurysms 
without oxtravasation o! dye or blood wore excluded, 
Rosuffs: 1304 catheteriznliona that tncktdcd BD of tire PAs wore per- 
termed over 14 year period at out institution, PA rt0pt~.~ro was ldonttltod by 
frank hemoptyaia and/or nnglogrophlc oxtravasntlon in 22 (1.7%) catheteri- 
zations in 2f patients (ago 5 month~--41 yonrs), 
Medical management Is summarized in the tuttnwlng table: 
Th~r~npy CPn INO lX TX ,0,511V EINT 
~1 et PI~ ;t1~2 6/22 171~2 6122 7t22 
CPR ~, cnrdiopulmonnly re~uecllnt~nn, INO - inntrnp¢ nuppott, TX ~ trnn~fuelnn, BV = 
blend volume, EINT = ~lfllOfflt~at Illttlt)tltion 
Five patients died, Throe died from nn~ontrotlablo pulmonary hemorrhage; 
two the day of catheterization, and one 7 dny~ later, Two pnttont~ who had 
balloon tnmponnde of the rt~plurod PA died; one at tire tlm~ of BD, and one 
2 day~ po~f cnthntonzntlon, niter ~urvlving n prolonged resuscitation and 
~urglcnt repair, In four patients the deranged PA was ~uccesslully oocludod 
with cafheter.deployod ptoel coils,, nil survived, 
Cencfl~sten: PallenI~ wllh PA ruptnm nt~eciatod with ~3D may require 
tltfOllBIvo medical mnnsgoment, however, nddlttonnl ntanagomont ~tratogios 
am nocossnry to prevent mortality, Coil occlusion of Ibo damaged PA ~s a 
uselt~l technique for mnnagnment at PA trauma duo to BD nnd may provenl 
fatal hemorrhage 
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~4~ 18-Year Experience With Transseptal Procedures 
- - -  Through Baffles, Conduits and Other intra-atrlsl 
Patches 
H,G El,Said, F,F, Ing, M,R, Nil;ill, R,G, Grilka, C, Morns, $, Beck, 
13. Goffy.Hou,'~owright t,,~ Dyer, C E, Mnllins #'~d~atnc Card~olO.ClV, To~'~ 
Cltildron~ Hospit#l,£~avIor College Of It,fod~cmt~. HoltsfOr~, Tox,l,,$. USA 
Backgm~md: Tire presence of an lntra-atrial pnfcl~ ~IAP) has been considered 
a relative contm~ndication to transseptal puncture (TSP). The purpose at th~s 
study is to determine tl~o efficacy and safety of TSP tl~mugh baffles, conduits, 
pericardial patellas and other prosthetic materials in the 1airs-atrial septum 
Methods: RoeoKts el ~11 podiatric pati~,nfs wi!h t~P who undonNent TSP 
in Texas Children's Hospital from November 1979 through July 1997 were 
reviewed, including indications, technical difficulties and ochocardiograms 
specifically addressing ¢osidual leaks. 
Result,~ In over 2000 TSP portormod urm q tllis penod. 37 patients had an 
lAP Cardiac diagnoses included d-transL~osthon ftile groat arteries following 
Mustard (7) or Sen=ling procedure (6), single ventricle vanant post-Fonfan 
operation (2), total anomalous venous return repair (4), atriovontricular canal 
=epa, (9!. an~.f at.a~ septat detect wltl~ patch repair (9), Pahonts' age ranged 
from 1 to 43 years (moan ago 7 years). The duration from the time of surgical 
repair to TSP ranged from 0 t to 21 years {moan age 5 years!. Indications ot 
TSP included putmonaq/vein evaluation with balloon dilation an@'or stenting 
{ 10), fenestration ottllo atrial baffle (1), prosthetic mitral valve evaluation (1), 
and avoidance of tomoral artery trauma (14). The lAP was traversed in 3&~37 
patients t97%), followed by diagnostic and, or therapeutic prograde loll-heart 
catheterization, No complications were encountered No residual shunting 
was prosent by follow up echocardiography, except in one case in which the 
Fontan ballle was intentionally ienestrated 
Conclt~s~on. Transsoptal puncture through an intra-atrial patch is sate, 
This technique is effeehve in permitting diagnostic and therapeutic left heart 
catheterizatzon and does not result in residual shunhng through the patch 
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La04~_j Catheter-based Pharmacomechanlcal Treatment  of 
Major Thromboembol l sm In Infants and Chi ldren 
J J  Rome. A Rob "~so ~ k id Brtdges. KE  Fellows Ch~ldrens Hospital of 
Philadelphia, Philadelphia, PA. USA 
Background The optimal therapy for major thromboemboembolism (TE~ [n 
cL:ldhood ~s unknown TE are rare b J: often hfe-threafgnmg i.1 pediatrics We 
report our expenence with pharmacomechanica) treatment ~PMT) for TE =n 
children. 
Met%'Yis: Patients w~th emodynam=cah~, significant TE were candidates 
for PMT, Catheter access was obtained tallowed by Clot maceration with 
wires ancLor balloon angtoplasty. D=rect pulse-spray infusion of urokinase 
Luk: 4400 Ukg), followed by continuous infusion for 48 h was performed 
when not contra=ndlcated ~5 6~. 
Resrrlts Six patients underv,,ent PMT Two were neonates wdhout con- 
genital heart d~sease tCHD'~: one w=th saddle pulmonary, embolus (PE~ was 
profoundly hypo'~emic and one wtlh aortic tllfombo=us had pulse~ess lower 
extremities and acidosis. Fo~.=r patients (4-13 y) had CHD: 2 with PE (both 
after Fontan), and 2 with innominato vein thrembus (one post Fonfan and 
end post transplant), Clots completely resolved In 4 patients while vessel 
potency was reestablished with pomlstent clot in 2. Clinical Improvement 
associated witi~ clot lysts in neonates included resolution of hypoxomia (I/1) 
and normalization of extremity perfuslon (1/1), In CHD patients effusions 
resolved In 2/2, and central venous pressure normalized in 1/3, The neonate 
with saddle PE had evidence of Infroventrlcutar hemorrhage within 48 hm. 
Tills Infant was the only patient in the series not treated with uk. At fotlowup 
3 m to 3 y, no p~llont has hr~d symptomatic recurrence, 
Concltlston: PMT Is a safe and effective moons of treating mater throm- 
botic events in Infants and children, 
Cardiac Transplantation: Basic Science 
Aspects 
Monday, Mamh 30, 1998, 10:30 a,m,-Noon 
Georgia World Congress Center, Room 254W 
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[ 8.0§-~ Small Platslct Thrombl Contribute to Neolnt lmal 
......... Formation In AIIograft Vascular Disease by Bridging 
the inflammatory and Smooth Muscle Cell 
Responses 
L H. Chow, J, Jiang, R, Zhong, J,G, Pckonng Roberts Research Institute, 
Lonaon, Onhlno, Can~lc/~! 
Platelet thmmbi contribute signiliciantly to plaque progression in typical ath- 
emsclomsis, but little is known of their rote in allograft vascular disoas(~ To 
study the latter, wo histologically examined mouse aodie allograffs (C57BLJ6 
[H-2t'l to BALB/c [H-2"]) during oady noointimal formation (days 1-24) 
Mixed cellular advontitial inflammation at day 5 was followed by on intense 
accumulation of inflammatory coils along the intima by days 9-f  ! The tat- 
tar ceils wore mostly mononuclear and displayed markers for macmphagos 
(Mac-l') and T cells (CD4' or CD8*) but not B celts (B220) By day f5. 
there was a virtual replacement el the initial intlammatonj cell response with 
small clusters o1 platolet Ihmmbi along the luminal sudaee. At days 15-21. 
lUXtaluminal platelot thrombi were progressively covered and intiltrated by 
shoots of vascular smooth muscle cells (smooth muscle ,-actin". desmin ° ), 
with incipient accumulation of oxtracellular matrix (Movat's pentachrome). A 
well defined neointima was detected by day 24, with the typical histolog~c 
appearances ot allograft vascular disease The sequence of intimal inflam- 
mation, platelet hrombi, and neointimal oxpans=on was absent in syngene=c 
(h=stocompatible) aortic gratts 
Thus, platelet thmmbi follow inflammatory miury and appear to promote 
subsequent neointimal formation Th=s potent=ally vital but non-=mmuno as- 
pect ot lea=on development has not been trad=honally well recogmzed as a 
part of allogratt vascular disease. 
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1805-21 Estradlol Inhibits A l lograf t  Arteriosclerosis by 
Estrogen Receptor a and ~ Act ivat ion 
S, Saito, H. Lou, P.W. Ramwell. M.L. Foegh. Georgetown University Med~ca! 
Center. Washington PC., USA 
Background: We discovered that inhibition ot transplant artenoscleresis by 
estradiol-171~ rE2) is associated with both down-regulation of MHC class II 
antigen expression and inhibition of macrophage infiltration. These inhibdory 
effects may require estrogen receptor activation in the allograft vessel, we 
treated the recipients with daily inlection ot estradiol ,~ and ,'~ receptor antag- 
onist ZM-182780 ~ZM) 
Method: Orthotopic abdominal aorta altograft transplantation was per- 
formed wdh male Brown-Norway rats as donors and male Lewis rats as re- 
cipients. Recipients {N = 18) were randomly divided into four groups treated 
from day 2 until day 21 posttransplantation with either placebo (vehiclet. 
E2 (20 ~tg/kg'day), ZM (2 mg kgdayL or E2 ÷ ZM. Myointlmal thickening 
(% MT) was measured by morphometry of cross sections ot the allograffs. 
MHC class II antigen expression and macrophage infiltration were graded 
semiquantit ,ve!y on a scale from 0 to +3 following immunohistostaining. 
Results: The effect ot treatment wLth estradiol rE2) and a competitive E2 
receptor antagonist (ZM) on °o MT. MHCtl, Macrophage Infiltration was as 
shown in the table. 
Conclusion: Estradiol inhibition of myointimal thickening. MHC class II 
antigen expression and macrcphage inhltration was reversed by concomi- 
tant administration of a competitive estrogen ,, and 5 receptor antagonist 
suggesting that estrogen receptor actwation inhibits transplant artenosctero- 
sis 
